APEX1 and neoplasm: Given the results described above showing preferential killing of tumor cells with this drug combination, it is likely that this decrease in CA9 positivity results from a shift in the tumor-to-CAF ratio within these spheroid co-cultures following dual-targeting of APE1/Ref-1 and CA9.